AdvanSix (ASIX) Q3 2024 earnings summary

Executive summary

• Q3 2024 sales reached $398 million, up 23% year-over-year, driven by higher volumes, favorable pricing, and strong demand for ammonium sulfate and acetone.

• Net income for Q3 2024 was $22.3 million, reversing a prior year loss, with adjusted EPS at $0.88.

• Free cash flow improved to $27 million, with cash flow from operations at $57 million, both up significantly year-over-year.

• Awarded a $12 million USDA grant for the SUSTAIN program, supporting expansion of granular ammonium sulfate production.

• Leadership transition with Sidd Manjeshwar appointed CFO effective October 1, while former CFO Mike Preston remains in an advisory role through year-end.

Financial highlights

• Adjusted EBITDA was $53.2 million (13.4% margin), up from $7.3 million (2.3% margin) in Q3 2023.

• Q3 2024 net income: $22.3 million; adjusted EPS: $0.88; free cash flow: $27 million.

• Capital expenditures were $30.5 million, up $5.4 million year-over-year, reflecting maintenance and growth investments.

• Cash and cash equivalents at quarter-end were $17.3 million, with $284 million available under revolving credit.

Outlook and guidance

• 2024 capital expenditures projected at $135–$140 million, with 2025 expected to be modestly higher due to project timing.

• Ammonium sulfate order book sold out through year-end, with strong demand and favorable spring outlook.

• Q4 2024 pre-tax income expected to be negatively impacted by $17 million due to extended Hopewell plant turnaround, including $10 million in fixed costs and $7 million in lost sales.

• North American nylon spreads and global acetone supply/demand expected to modestly improve.